ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis. (October 2022) - Levy, M.; Ferraro, G.B.; Planoutene, M.; Li, L.; Han, Y.; Varicchio, L.; Fournier, S.; An, X.; Morris, S.J.; Koehler, M.; Hoffman, R.; Fretland, A.J.; et al.